| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 11752688 15322242 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.15 | 11473722 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.26 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.26 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
| MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.52 | 17084956 |
| MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
5.37 | 15336622 |
| MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
12.29 | 16142846 |
| MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
12.29 | 19761891 |
| OMIM:180500 |
AXENFELD-RIEGER SYNDROME, TYPE 1 |
marker/mechanism |
|
| 15378534 10644443 10502778 14630904 14623826 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.73 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.73 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.87 | 17261762 12948864 16675129 14630087 18497071 19861407 17018787 17289903 |
| MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
1.87 | 18628248 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
| MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.99 | 16962696 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.86 | 16111702 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.25 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
3.25 | 19519916 12508355 |
| MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
5.31 | 17234771 |
| MESH:D006332 |
Cardiomegaly |
|
Quercetin |
7.26 | 19794523 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
7.26 | 18670907 18850075 16120746 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.19 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.19 | 18566989 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.44 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.44 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 16354765 8697196 15668235 12621046 15340226 |
| MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
2.45 | 19440933 15741050 11134977 16640504 17148506 19056647 17191121 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
2.19 | 18095365 18852136 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 10499585 14623826 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 15322242 10048152 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.97 | 19496084 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.66 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
7.48 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.48 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.15 | 18566989 11473722 19148513 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.51 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.51 | 20131406 19236843 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
16.97 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Quercetin |
16.97 | 19474275 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.97 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Quercetin |
3.56 | 19804834 |
| MESH:D005910 |
Glioma |
|
Quercetin |
3.14 | 17643826 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
marker/mechanism |
|
| 10499585 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 11294989 10048152 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.48 | 16221962 19772884 19176532 18467677 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.48 | 16120746 12621046 15340226 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.48 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.19 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 8697196 16354765 15340226 16959395 18606429 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
10.14 | 20558911 |
| MESH:D006943 |
Hyperglycemia |
|
Quercetin |
10.14 | 18262572 11834736 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.10 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Quercetin |
9.10 | 18356687 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.10 | 18850075 18670907 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.98 | 12200463 12878042 |
| MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.95 | 16624496 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.77 | 16393666 16627594 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.77 | 16306350 |
| OMIM:137600 |
IRIDOGONIODYSGENESIS, TYPE 2 |
marker/mechanism |
|
| 10502778 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
| MESH:D007627 |
Keloid |
|
Quercetin |
5.31 | 17086741 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.95 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.95 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
Quercetin |
10.95 | 16962696 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.06 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.06 | 15610895 |
| MESH:D007938 |
Leukemia |
|
Quercetin |
3.27 | 17468513 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.16 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.16 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
5.16 | 12741479 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.16 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.92 | 15890375 20007298 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
7.92 | 18980244 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.92 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
6.46 | 19519916 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.46 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
2.48 | 16280456 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.48 | 11884234 19555203 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.72 | 11807958 17203775 16891317 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.93 | 19453300 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.05 | 19151258 |
| MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
6.05 | 19595682 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
15.45 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
15.45 | 16411023 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
15.45 | 19207477 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.45 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
Quercetin |
5.45 | 15185748 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.13 | 17289903 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.58 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.58 | 14600291 |
| MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.67 | 17929310 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.52 | 19495926 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.19 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
5.19 | 19005980 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
2.93 | 16965848 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
| MESH:C537884 |
Peters anomaly |
marker/mechanism |
|
| |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.94 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
9.94 | 19056647 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11896295 11222880 11399792 11118676 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.17 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.68 | 17024972 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.68 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.68 | 17292933 14715546 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
| MESH:C535684 |
Ring dermoid of cornea |
marker/mechanism |
|
| |
| MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.99 | 16862918 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.13 | 19048282 |
| MESH:D014071 |
Tooth Abnormalities |
marker/mechanism |
|
| 10499585 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
2.89 | 16720314 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |